Drugging tRNA aminoacylation

References

• Ibba M, Soll D. Quality control mechanisms during translation. Science. 1999;286:1893–7. doi:10.1126/science.286.5446.1893
   PubMed Web of Science ®Google Scholar
• Ibba M, Curnow AW, Soll D. Aminoacyl-tRNA synthesis: divergent routes to a common goal. Trends Biochem Sci. 1997;22:39–42. doi:10.1016/S0968-0004(96)20033-7
   PubMed Web of Science ®Google Scholar
• Smith YA. tRNA on the ribosome: A waggle theory. tRNA: Structure, biosynthesis and function. Washington: DC: ASM Press; 1995.pp. 443–69
   Google Scholar
• Lincecum TL, Jr., Tukalo M, Yaremchuk A, et al. Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase. Mol Cell. 2003;11:951–63. doi:10.1016/S1097-2765(03)00098-4
   PubMed Web of Science ®Google Scholar
• Ibba M, Soll D. Aminoacyl-tRNA synthesis. Annu Rev Biochem. 2000;69:617–50. doi:10.1146/annurev.biochem.69.1.617
   PubMed Web of Science ®Google Scholar
• de Duve C Transfer RNAs: The second genetic code. Nature. 1988;333:117–8. doi:10.1038/333117a0
   PubMed Web of Science ®Google Scholar
• Fersht AR, Ashford JS, Bruton CJ, et al. Active site titration and aminoacyl adenylate binding stoichiometry of aminoacyl-tRNA synthetases. Biochemistry. 1975;14:1–4. doi:10.1021/bi00672a001
   PubMed Web of Science ®Google Scholar
• Francklyn CS, First EA, Perona JJ, et al. Methods for kinetic and thermodynamic analysis of aminoacyl-tRNA synthetases. Methods. 2008;44:100–18. doi:10.1016/j.ymeth.2007.09.007
   PubMed Web of Science ®Google Scholar
• Cestari I, Stuart K. A spectrophotometric assay for quantitative measurement of aminoacyl-tRNA synthetase activity. J Biomol Screen. 2013;18:490–7. doi:10.1177/1087057112465980
   PubMedGoogle Scholar
• Loftfield RB. The mechanism of aminoacylation of transfer RNA. Prog Nucleic Acid Res Mol Biol. 1972;12:87–128. doi:10.1016/S0079-6603(08)60660-1
   PubMedGoogle Scholar
• Eigner EA, Loftfield RB. Kinetic techniques for the investigation of amino acid: tRNA ligases (aminoacyl-tRNA synthetases, amino acid activating enzymes). Methods Enzymol. 1974;29:601–19. doi:10.1016/0076-6879(74)29053-0
   PubMedGoogle Scholar
• Wolfson AD, Pleiss JA, Uhlenbeck OC. A new assay for tRNA aminoacylation kinetics. RNA. 1998;4:1019–23. doi:10.1017/S1355838298980700
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang Y. Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation. Nucleic Acids Res. 2008;36:1654–64. doi:10.1093/nar/gkm1180
   PubMed Web of Science ®Google Scholar
• Orelle C, Szal T, Klepacki D, et al. Identifying the targets of aminoacyl-tRNA synthetase inhibitors by primer extension inhibition. Nucleic Acids Res. 2013;41:e144. doi:10.1093/nar/gkt526
   PubMed Web of Science ®Google Scholar
• Tuckey C, Asahara H, Zhou Y, et al. Protein synthesis using a reconstituted cell-free system. Curr Protoc Mol Biol. 2014;108: 16 31 1–22
   PubMedGoogle Scholar
• Vondenhoff GH, Van Aerschot A. Aminoacyl-tRNA synthetase inhibitors as potential antibiotics. Eur J Med Chem. 2011;46:5227–36. doi:10.1016/j.ejmech.2011.08.049
   PubMed Web of Science ®Google Scholar
• Chopra S, Reader J. tRNAs as antibiotic targets. Int J Mol Sci. 2014;16:321–49. doi:10.3390/ijms16010321
   PubMed Web of Science ®Google Scholar
• Lionta E, Spyrou G, Vassilatis DK, et al. Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem. 2014;14:1923–38. doi:10.2174/1568026614666140929124445
   PubMed Web of Science ®Google Scholar
• Coates AR, Halls G, Hu Y. Novel classes of antibiotics or more of the same? Br J Pharmacol. 2011;163:184–94. doi:10.1111/j.1476-5381.2011.01250.x
   PubMed Web of Science ®Google Scholar
• Becker D, Selbach M, Rollenhagen C, et al. Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature. 2006;440:303–7. doi:10.1038/nature04616
   PubMed Web of Science ®Google Scholar
• Loman NJ, Pallen MJ. Twenty years of bacterial genome sequencing. Nature reviews Microbiology. 2015;13:787–94. doi:10.1038/nrmicro3565
   PubMed Web of Science ®Google Scholar
• Fang P, Guo M. Evolutionary limitation and opportunities for developing tRNA synthetase inhibitors with 5-binding-mode classification. Life (Basel). 2015;5:1703–25
   PubMedGoogle Scholar
• Wilson DN. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol. 2014;12:35–48. doi:10.1038/nrmicro3155
   PubMed Web of Science ®Google Scholar
• Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010;8:423–35. doi:10.1038/nrmicro2333
   PubMed Web of Science ®Google Scholar
• O'Donoghue P, Luthey-Schulten Z. On the evolution of structure in aminoacyl-tRNA synthetases. Microbiol Mol Biol Rev. 2003;67:550–73. doi:10.1128/MMBR.67.4.550-573.2003
   PubMed Web of Science ®Google Scholar
• Marck C, Grosjean H. tRNomics: analysis of tRNA genes from 50 genomes of Eukarya, Archaea, and Bacteria reveals anticodon-sparing strategies and domain-specific features. RNA. 2002;8:1189–232. doi:10.1017/S1355838202022021
   PubMed Web of Science ®Google Scholar
• Woese CR, Olsen GJ, Ibba M, et al. Aminoacyl-tRNA synthetases, the genetic code, and the evolutionary process. Microbiol Mol Biol Rev. 2000;64:202–36. doi:10.1128/MMBR.64.1.202-236.2000
   PubMed Web of Science ®Google Scholar
• Schimmel P, Tao J, Hill J. Aminoacyl tRNA synthetases as targets for new anti-infectives. Faseb J. 1998;12:1599–609
   PubMed Web of Science ®Google Scholar
• Silvian LF, Wang J, Steitz TA. Insights into editing from an ile-tRNA synthetase structure with tRNAile and mupirocin. Science. 1999;285:1074–7. doi:10.1126/science.285.5430.1074
   PubMed Web of Science ®Google Scholar
• Pines M, Spector I. Halofuginone – the multifaceted molecule. Molecules. 2015;20:573–94. doi:10.3390/molecules20010573
   PubMed Web of Science ®Google Scholar
• Tavaborole topical solution (Kerydin) for onychomycosis. Med Lett Drugs Ther. 2015;57:35–6
   PubMed Web of Science ®Google Scholar
• Hughes J, Mellows G. Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J. 1980;191:209–19. doi:10.1042/bj1910209
   PubMed Web of Science ®Google Scholar
• Nakama T, Nureki O, Yokoyama S. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase. J Biol Chem. 2001;276:47387–93. doi:10.1074/jbc.M109089200
   PubMed Web of Science ®Google Scholar
• Zhou H, Sun L, Yang XL, et al. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase. Nature. 2013;494:121–4. doi:10.1038/nature11774
   PubMed Web of Science ®Google Scholar
• Abibi A, Ferguson AD, Fleming PR, et al. The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability. J Biol Chem. 2014;289:21651–62. doi:10.1074/jbc.M114.574061
   PubMed Web of Science ®Google Scholar
• Fang P, Yu X, Jeong SJ, et al. Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase. Nat Commun. 2015;6:6402. doi:10.1038/ncomms7402
   PubMed Web of Science ®Google Scholar
• Giege R, Sissler M, Florentz C. Universal rules and idiosyncratic features in tRNA identity. Nucleic Acids Res. 1998;26:5017–35. doi:10.1093/nar/26.22.5017
   PubMed Web of Science ®Google Scholar
• Freyhult E, Moulton V, Ardell DH. Visualizing bacterial tRNA identity determinants and antideterminants using function logos and inverse function logos. Nucleic Acids Res. 2006;34:905–16. doi:10.1093/nar/gkj478
   PubMed Web of Science ®Google Scholar
• Ardell DH. Computational analysis of tRNA identity. FEBS letters. 2010;584:325–33. doi:10.1016/j.febslet.2009.11.084
   PubMed Web of Science ®Google Scholar
• Saks ME, Sampson JR, Abelson JN. The transfer RNA identity problem: A search for rules. Science. 1994;263:191–7. doi:10.1126/science.7506844
   PubMed Web of Science ®Google Scholar
• Giege R. Toward a more complete view of tRNA biology. Nat Struct Mol Biol. 2008;15:1007–14. doi:10.1038/nsmb.1498
   PubMed Web of Science ®Google Scholar
• Carter CW, Jr., Wolfenden R. tRNA acceptor stem and anticodon bases form independent codes related to protein folding. Proc Natl Acad Sci U S A. 2015;112:7489–94. doi:10.1073/pnas.1507569112
   PubMed Web of Science ®Google Scholar
• Crothers DM, Seno T, Soll G. Is there a discriminator site in transfer RNA? Proc Natl Acad Sci U S A. 1972;69:3063–7. doi:10.1073/pnas.69.10.3063
   PubMed Web of Science ®Google Scholar
• Wende S, Bonin S, Gotze O, et al. The identity of the discriminator base has an impact on CCA addition. Nucleic Acids Res. 2015;43:5617–29. doi:10.1093/nar/gkv471
   PubMed Web of Science ®Google Scholar
• Ambrogelly A, Gundllapalli S, Herring S, et al. Pyrrolysine is not hardwired for cotranslational insertion at UAG codons. Proc Natl Acad Sci U S A. 2007;104:3141–6. doi:10.1073/pnas.0611634104
   PubMed Web of Science ®Google Scholar
• Shiba K, Motegi H, Schimmel P. Maintaining genetic code through adaptations of tRNA synthetases to taxonomic domains. Trends Biochem Sci. 1997;22:453–7. doi:10.1016/S0968-0004(97)01135-3
   PubMed Web of Science ®Google Scholar
• Putz J, Giege R, Florentz C. Diversity and similarity in the tRNA world: overall view and case study on malaria-related tRNAs. FEBS letters. 2010;584:350–8. doi:10.1016/j.febslet.2009.11.050
   PubMed Web of Science ®Google Scholar
• Salinas-Giege T, Giege R, Giege P. tRNA biology in mitochondria. Int J Mol Sci. 2015;16:4518–59. doi:10.3390/ijms16034518
   PubMed Web of Science ®Google Scholar
• Geslain R, Pan T. Functional analysis of human tRNA isodecoders. J Mol Biol. 2010;396:821–31. doi:10.1016/j.jmb.2009.12.018
   PubMed Web of Science ®Google Scholar
• Breitschopf K, Gross HJ. The exchange of the discriminator base A73 for G is alone sufficient to convert human tRNA(Leu) into a serine-acceptor in vitro. EMBO J. 1994;13:3166–9
   PubMed Web of Science ®Google Scholar
• Achsel T, Gross HJ. Identity determinants of human tRNA(Ser): sequence elements necessary for serylation and maturation of a tRNA with a long extra arm. EMBO J. 1993;12:3333–8
   PubMed Web of Science ®Google Scholar
• Stehlin C, Burke B, Yang F, et al. Species-specific differences in the operational RNA code for aminoacylation of tRNAPro. Biochemistry. 1998;37:8605–13. doi:10.1021/bi980364s
   PubMed Web of Science ®Google Scholar
• Hipps D, Shiba K, Henderson B, et al. Operational RNA code for amino acids: species-specific aminoacylation of minihelices switched by a single nucleotide. Proc Natl Acad Sci U S A. 1995;92:5550–2. doi:10.1073/pnas.92.12.5550
   PubMed Web of Science ®Google Scholar
• Nazarenko IA, Peterson ET, Zakharova OD, et al. Recognition nucleotides for human phenylalanyl-tRNA synthetase. Nucleic Acids Res. 1992;20:475–8. doi:10.1093/nar/20.3.475
   PubMed Web of Science ®Google Scholar
• Pham JS, Dawson KL, Jackson KE, et al. Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites. Int J Parasitol Drugs Drug Resist. 2014;4:1–13. doi:10.1016/j.ijpddr.2013.10.001
   PubMed Web of Science ®Google Scholar
• Foth BJ, McFadden GI. The apicoplast: a plastid in Plasmodium falciparum and other Apicomplexan parasites. Int Rev Cytol. 2003;224:57–110. doi:10.1016/S0074-7696(05)24003-2
   PubMedGoogle Scholar
• Larson ET, Kim JE, Zucker FH, et al. Structure of Leishmania major methionyl-tRNA synthetase in complex with intermediate products methionyladenylate and pyrophosphate. Biochimie. 2011;93:570–82. doi:10.1016/j.biochi.2010.11.015
   PubMed Web of Science ®Google Scholar
• Larson ET, Kim JE, Castaneda LJ, et al. The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimer. J Mol Biol. 2011;409:159–76. doi:10.1016/j.jmb.2011.03.026
   PubMed Web of Science ®Google Scholar
• Grosjean H, de Crecy-Lagard V, Marck C. Deciphering synonymous codons in the three domains of life: Co-evolution with specific tRNA modification enzymes. FEBS letters. 2010;584:252–64. doi:10.1016/j.febslet.2009.11.052
   PubMed Web of Science ®Google Scholar
• Weigele P, Raleigh EA. Biosynthesis and Function of Modified Bases in Bacteria and Their Viruses. Chem Rev. 2016;116:12655–87. doi:10.1021/acs.chemrev.6b00114
   PubMed Web of Science ®Google Scholar
• Cantara WA, Crain PF, Rozenski J, et al. The RNA Modification Database, RNAMDB: 2011 update. Nucleic Acids Res. 2011;39:D195–201. doi:10.1093/nar/gkq1028
   PubMed Web of Science ®Google Scholar
• Machnicka MA, Milanowska K, Osman Oglou O, et al. MODOMICS: A database of RNA modification pathways–2013 update. Nucleic Acids Res. 2013;41:D262–7. doi:10.1093/nar/gks1007
   PubMed Web of Science ®Google Scholar
• Machnicka MA, Olchowik A, Grosjean H, et al. Distribution and frequencies of post-transcriptional modifications in tRNAs. RNA Biol. 2014;11:1619–29. doi:10.4161/15476286.2014.992273
   PubMed Web of Science ®Google Scholar
• Giegé R LJ. Transfer RNA aminoacylation and modified nucleosides. In: H G, ed. DNA and RNA modification enzymes: Structure, mechanism, function and evolution. Austin, Texas, USA: Landes Bioscience; 2009.p. 476–92
   Google Scholar
• Grosjean H, Westhof E. An integrated, structure- and energy-based view of the genetic code. Nucleic Acids Res. 2016;44:8020–40. doi:10.1093/nar/gkw608
   PubMed Web of Science ®Google Scholar
• Perret V, Garcia A, Grosjean H, et al. Relaxation of a transfer RNA specificity by removal of modified nucleotides. Nature. 1990;344:787–9. doi:10.1038/344787a0
   PubMed Web of Science ®Google Scholar
• Putz J, Florentz C, Benseler F, et al. A single methyl group prevents the mischarging of a tRNA. Nat Struct Biol. 1994;1:580–2. doi:10.1038/nsb0994-580
   PubMedGoogle Scholar
• Limbach PA, Crain PF, McCloskey JA. Summary: the modified nucleosides of RNA. Nucleic Acids Res. 1994;22:2183–96. doi:10.1093/nar/22.12.2183
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis. 2009;48:1–12. doi:10.1086/595011
   PubMed Web of Science ®Google Scholar
• Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11:297–308. doi:10.1586/eri.13.12
   PubMed Web of Science ®Google Scholar
• Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011;86:156–67. doi:10.4065/mcp.2010.0639
   PubMed Web of Science ®Google Scholar
• Bonnefond L, Giege R, Rudinger-Thirion J. Evolution of the tRNA(Tyr)/TyrRS aminoacylation systems. Biochimie. 2005;87:873–83. doi:10.1016/j.biochi.2005.03.008
   PubMed Web of Science ®Google Scholar
• Becker HD, Giege R, Kern D. Identity of prokaryotic and eukaryotic tRNA(Asp) for aminoacylation by aspartyl-tRNA synthetase from Thermus thermophilus. Biochemistry. 1996;35:7447–58. doi:10.1021/bi9601058
   PubMed Web of Science ®Google Scholar
• Kotra LP, Haddad J, Mobashery S. Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob Agents Chemother. 2000;44:3249–56. doi:10.1128/AAC.44.12.3249-3256.2000
   PubMed Web of Science ®Google Scholar
• Davis BD. Mechanism of bactericidal action of aminoglycosides. Microbiol Rev. 1987;51:341–50
   PubMedGoogle Scholar
• Mikkelsen NE, Johansson K, Virtanen A, et al. Aminoglycoside binding displaces a divalent metal ion in a tRNA-neomycin B complex. Nat Struct Biol. 2001;8:510–4. doi:10.1038/88569
   PubMedGoogle Scholar
• Kirk SR, Tor Y. tRNA(Phe) binds aminoglycoside antibiotics. Bioorg Med Chem. 1999;7:1979–91. doi:10.1016/S0968-0896(99)00170-4
   PubMed Web of Science ®Google Scholar
• Discovery T. Staphylococcus aureus 201 HTS-assay white paper. 2011
   Google Scholar
• Walter F, Putz J, Giege R, et al. Binding of tobramycin leads to conformational changes in yeast tRNA(Asp) and inhibition of aminoacylation. EMBO J. 2002;21:760–8. doi:10.1093/emboj/21.4.760
   PubMed Web of Science ®Google Scholar
• Wang B, Wilkinson KA, Weeks KM. Complex ligand-induced conformational changes in tRNA(Asp) revealed by single-nucleotide resolution SHAPE chemistry. Biochemistry. 2008;47:3454–61. doi:10.1021/bi702372x
   PubMed Web of Science ®Google Scholar
• Hori Y, Bichenkova EV, Wilton AN, et al. Synthetic inhibitors of the processing of pretransfer RNA by the ribonuclease P ribozyme: enzyme inhibitors which act by binding to substrate. Biochemistry. 2001;40:603–8. doi:10.1021/bi002378f
   PubMed Web of Science ®Google Scholar
• Hori Y, Rogert MC, Tanaka T, et al. Porphyrins and porphines bind strongly and specifically to tRNA, precursor tRNA and to M1 RNA and inhibit the ribonuclease P ribozyme reaction. Biochim Biophys Acta. 2005;1730:47–55. doi:10.1016/j.bbaexp.2005.06.003
   PubMedGoogle Scholar
• Rock FL, Mao W, Yaremchuk A, et al. An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site. Science. 2007;316:1759–61. doi:10.1126/science.1142189
   PubMed Web of Science ®Google Scholar
• Chopra S, Palencia A, Virus C, et al. Plant tumour biocontrol agent employs a tRNA-dependent mechanism to inhibit leucyl-tRNA synthetase. Nat Commun. 2013;4:1417. doi:10.1038/ncomms2421
   PubMed Web of Science ®Google Scholar
• Kirillov S, Vitali LA, Goldstein BP, et al. Purpuromycin: an antibiotic inhibiting tRNA aminoacylation. Rna. 1997;3:905–13
   PubMed Web of Science ®Google Scholar
• Liu Y, Tidwell RR, Leibowitz MJ. Inhibition of in vitro splicing of a group I intron of Pneumocystis carinii. J Eukaryot Microbiol. 1994;41:31–8. doi:10.1111/j.1550-7408.1994.tb05931.x
   PubMed Web of Science ®Google Scholar
• Miletti KE, Leibowitz MJ. Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition. Antimicrob Agents Chemother. 2000;44:958–66. doi:10.1128/AAC.44.4.958-966.2000
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bell A, Perlman PS, et al. Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae. RNA. 2000;6:937–51. doi:10.1017/S1355838200991726
   PubMed Web of Science ®Google Scholar
• Putignano V, Rosato A, Banci L, et al. MetalPDB in 2018: A database of metal sites in biological macromolecular structures. Nucleic Acids Res. 2018;46(D1):D459–D464. doi:10.1093/nar/gkx989
   PubMed Web of Science ®Google Scholar
• Draper DE. A guide to ions and RNA structure. RNA. 2004;10:335–43. doi:10.1261/rna.5205404
   PubMed Web of Science ®Google Scholar
• Hermann T. Strategies for the Design of Drugs Targeting RNA and RNA-Protein Complexes. Angewandte Chemie. 2000;39:1890–904. doi:10.1002/1521-3773(20000602)39:11%3c1890::AID-ANIE1890%3e3.0.CO;2-D
   Google Scholar
• Chen L, Calin GA, Zhang S. Novel insights of structure-based modeling for RNA-targeted drug discovery. J Chem Inf Model. 2012;52:2741–53. doi:10.1021/ci300320t
   PubMed Web of Science ®Google Scholar
• Deutscher M. The Effect of Polynucleotides on Aminoacyl-Rna Synthetases. 1. Inhibition by Synthetic Polynucleotides Biochem Biophys Res Commun. 1965;19:283–8. doi:10.1016/0006-291X(65)90455-9
   PubMed Web of Science ®Google Scholar
• Beltchev B, Grunberg-Manago M. Competitive inhibition of the acceptor activity of tRNA(Tyr II)(E. coli) by a combination of oligo G and a CCA terminated nineteen residue oligonucleotide of tRNA(Tyr II)(E. coli). FEBS letters. 1970;12:27–9. doi:10.1016/0014-5793(70)80586-5
   PubMed Web of Science ®Google Scholar
• Schimmel P. Aminoacyl tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAs. Annu Rev Biochem. 1987;56:125–58. doi:10.1146/annurev.bi.56.070187.001013
   PubMed Web of Science ®Google Scholar
• Moulinier L, Eiler S, Eriani G, et al. The structure of an AspRS-tRNA(Asp) complex reveals a tRNA-dependent control mechanism. EMBO J. 2001;20:5290–301. doi:10.1093/emboj/20.18.5290
   PubMed Web of Science ®Google Scholar
• Wolf YI, Aravind L, Grishin NV, et al. Evolution of aminoacyl-tRNA synthetases–analysis of unique domain architectures and phylogenetic trees reveals a complex history of horizontal gene transfer events. Genome Res. 1999;9:689–710
   PubMed Web of Science ®Google Scholar
• Keeling PJ. Genomics: Evolution of the genetic code. Curr Biol. 2016;26:R851–R3. doi:10.1016/j.cub.2016.08.005
   PubMed Web of Science ®Google Scholar
• Mukai T, Englert M, Tripp HJ, et al. Facile Recoding of Selenocysteine in Nature. Angewandte Chemie. 2016;55:5337–41. doi:10.1002/anie.201511657
   Google Scholar
• Fukai S, Nureki O, Sekine S, et al. Structural basis for double-sieve discrimination of L-valine from L-isoleucine and L-threonine by the complex of tRNA(Val) and valyl-tRNA synthetase. Cell. 2000;103:793–803. doi:10.1016/S0092-8674(00)00182-3
   PubMed Web of Science ®Google Scholar
• Bai F, Morcos F, Cheng RR, et al. Elucidating the druggable interface of protein-protein interactions using fragment docking and coevolutionary analysis. Proc Natl Acad Sci U S A. 2016;113:E8051–E8. doi:10.1073/pnas.1615932113
   PubMed Web of Science ®Google Scholar
• Watkins AM, Arora PS. Structure-based inhibition of protein-protein interactions. Eur J Med Chem. 2015;94:480–8. doi:10.1016/j.ejmech.2014.09.047
   PubMed Web of Science ®Google Scholar
• Forster C, Szkaradkiewicz K, Perbandt M, et al. Human tRNA(Gly) acceptor-stem microhelix: crystallization and preliminary X-ray diffraction analysis at 1.2 A resolution. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007;63:858–61. doi:10.1107/S1744309107041528
   PubMedGoogle Scholar
• Shiba K, Schimmel P, Motegi H, et al. Human glycyl-tRNA synthetase. Wide divergence of primary structure from bacterial counterpart and species-specific aminoacylation J Biol Chem. 1994;269:30049–55
   Google Scholar
• Mazauric MH, Reinbolt J, Lorber B, et al. An example of non-conservation of oligomeric structure in prokaryotic aminoacyl-tRNA synthetases. Biochemical and structural properties of glycyl-tRNA synthetase from Thermus thermophilus. Eur J Biochem/FEBS. 1996;241:814–26. doi:10.1111/j.1432-1033.1996.00814.x
   PubMedGoogle Scholar
• Qin X, Hao Z, Tian Q, et al. Cocrystal structures of glycyl-tRNA synthetase in complex with tRNA suggest multiple conformational states in glycylation. J Biol Chem. 2014;289:20359–69. doi:10.1074/jbc.M114.557249
   PubMed Web of Science ®Google Scholar
• Rodova M, Ankilova V, Safro MG. Human phenylalanyl-tRNA synthetase: cloning, characterization of the deduced amino acid sequences in terms of the structural domains and coordinately regulated expression of the alpha and beta subunits in chronic myeloid leukemia cells. Biochem Biophys Res Commun. 1999;255:765–73. doi:10.1006/bbrc.1999.0141
   PubMed Web of Science ®Google Scholar
• Finarov I, Moor N, Kessler N, et al. Structure of human cytosolic phenylalanyl-tRNA synthetase: evidence for kingdom-specific design of the active sites and tRNA binding patterns. Structure. 2010;18:343–53. doi:10.1016/j.str.2010.01.002
   PubMed Web of Science ®Google Scholar
• Abibi A, Ferguson AD, Fleming PR, et al. The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability. J Biol Chem. 2014;289:21651–62. doi:10.1074/jbc.M114.574061
   PubMed Web of Science ®Google Scholar
• Palencia A, Crepin T, Vu MT, et al. Structural dynamics of the aminoacylation and proofreading functional cycle of bacterial leucyl-tRNA synthetase. Nat Struct Mol Biol. 2012;19:677–84. doi:10.1038/nsmb.2317
   PubMed Web of Science ®Google Scholar
• Deng X, Qin X, Chen L, et al. Large Conformational Changes of Insertion 3 in Human Glycyl-tRNA Synthetase (hGlyRS) during Catalysis. J Biol Chem. 2016;291:5740–52. doi:10.1074/jbc.M115.679126
   PubMed Web of Science ®Google Scholar
• Wang C, Guo Y, Tian Q, et al. SerRS-tRNASec complex structures reveal mechanism of the first step in selenocysteine biosynthesis. Nucleic Acids Res. 2015;43:10534–45
   PubMed Web of Science ®Google Scholar
• Shen N, Guo L, Yang B, et al. Structure of human tryptophanyl-tRNA synthetase in complex with tRNATrp reveals the molecular basis of tRNA recognition and specificity. Nucleic Acids Res. 2006;34:3246–58. doi:10.1093/nar/gkl441
   PubMed Web of Science ®Google Scholar
• Crick FH. The origin of the genetic code. J Mol Biol. 1968;38:367–79. doi:10.1016/0022-2836(68)90392-6
   PubMed Web of Science ®Google Scholar
• Breitschopf K, Achsel T, Busch K, et al. Identity elements of human tRNA(Leu): structural requirements for converting human tRNA(Ser) into a leucine acceptor in vitro. Nucleic Acids Res. 1995;23:3633–7. doi:10.1093/nar/23.18.3633
   PubMed Web of Science ®Google Scholar
• Hou YM, Schimmel P. Evidence that a major determinant for the identity of a transfer RNA is conserved in evolution. Biochemistry. 1989;28:6800–4. doi:10.1021/bi00443a003
   PubMed Web of Science ®Google Scholar
• Juhling F, Morl M, Hartmann RK, et al. tRNAdb 2009: compilation of tRNA sequences and tRNA genes. Nucleic Acids Res. 2009;37:D159–62. doi:10.1093/nar/gkn772
   PubMed Web of Science ®Google Scholar